Atlas Trials

Stage IVB Hepatocellular Carcinoma AJCC v8

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IVB Hepatocellular Carcinoma AJCC v8

RecordFirmDate
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer (NCT05168163)Academic and Community Cancer Research United2022-05-27
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373)M.D. Anderson Cancer Center2022-04-29
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant (NCT05103904)Emory University2022-04-19
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma (NCT04430452)Mary Feng, MD2022-02-04
Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer (NCT04605731)City of Hope Medical Center2021-08-03
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)M.D. Anderson Cancer Center2021-05-12
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer (NCT04380545)M.D. Anderson Cancer Center2021-01-13
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers (NCT04221893)University of California, San Francisco2020-08-07
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver (NCT04175912)National Cancer Institute (NCI)2020-03-16
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D) (NCT03896646)M.D. Anderson Cancer Center2019-10-10
An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer (NCT04022746)M.D. Anderson Cancer Center2019-06-11
IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer (NCT03655002)City of Hope Medical Center2019-02-21
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer (NCT03695250)Edward Kim2018-10-16
Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer (NCT03439891)Robin Kate Kelley2018-04-16
Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma (NCT01176604)M.D. Anderson Cancer Center2010-08-04

Track Stage IVB Hepatocellular Carcinoma AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.